Adverse prognostic value of peritumoral vascular invasion: is it abrogated by adequate endocrine adjuvant therapy? Results from two International Breast Cancer Study Group randomized trials of chemoendocrine adjuvant therapy for early breast cancer.
暂无分享,去创建一个
A. Giobbie-Hurder | R. Gelber | B. Gusterson | A. Goldhirsch | G. Viale | M. Regan | A. Coates | E. Mallon | D. Crivellari | K. Price | M. Castiglione‐Gertsch | R. Golouh | R. Brown | E. Maiorano | A. Coates | P. Karlsson | C. Ohlschlegel | M. Mastropasqua | M. Colleoni | C. Öhlschlegel | A. Sonzogni | M. Mastropasqua